Marissa L. Ostroff
Clinical Associate Professor of Ambulatory Care
Department of Pharmacy Practice
Office: CSP 431
LinkedIn Account: Click Here
Marissa Ostroff received her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences in Boston, MA. Upon graduation Dr. Ostroff completed a PGY-1 Pharmacy Practice residency at the VA Connecticut Healthcare System in West Haven, CT. During her PGY-1 she received her Teaching and Learning Certification from the University of Connecticut School of Pharmacy. Dr. Ostroff went on to complete a PGY-2 in Geriatrics at the Durham VA Medical Center in Durham, NC. There she had the opportunity to precept PY4 students from the Campbell University College of Pharmacy and from the University of North Carolina Eshelman School of Pharmacy. Dr. Ostroff was also an adjunct instructor for the PY3 Pharmaceutical Care Lab at the University of North Carolina Eshelman School of Pharmacy. During her PGY-2 residency Dr. Ostroff also completed the Faculty Development Course in Clinical Teaching developed by the Stanford Faculty Development Center for Medical Teachers. Dr. Ostroff became a Board Certified Pharmacotherapy Specialist in 2013. Dr. Ostroff is currently a Clinical Assistant Professor of Ambulatory Care specializing in chronic disease state management and renal. Dr. Ostroff's areas of interest include, transitions of care, geriatrics, chronic disease state management, and long-term care.
- CO-IOR: PHAR 710: IPC GI/Nutrition/Hepatic
- CO-IOR: PHAR 752-01: Geriatrics, Beyond the Basics
- Instructor: PHAR 713: IPC Infectious Diseases II: STIs
- Instructor: PHAR 721: IPC Neuro/CNS: Alzheimer’s and Parkinson’s Disease
- Instructor: PHAR 724: Special Populations: Dementia, Delirium, End of Life Care and Long Term Care
- Instructor: PHAR 725: Applied Pharmacy Care III
Dr. Wolff’s research interests include transitions of care, chronic disease states, polypharmacy, and medication misuse in older adults.
Wolff ML, Cruz JL, Vanderman AJ, Brown JN. The effect of angiotensin II receptor blockers on hyperuricemia. Therapeutic Advances in Chronic Disease November 2015 vol. 6 no. 6 339-346
Cruz JL, Wolff ML, Vanderman AJ, Brown JN. The emerging role of tacrolimus in myasthenia gravis.Therapeutic Advances in Neurological Disorders. 2015 Feb; epub ahead of print
Long T, Dann S, Wolff ML, Brienza RS. Moving from silos to teamwork: integration of interprofessional trainees into a medical home model. J Interprof Care. 2014 Sep; 28(5): 473-4
Newsletter Article: “Update on Adult Vaccines”, CT-ASCP's SenioRx Care Perspective Winter 2013: Volume VII No. 5
- APhA-ASP: Operation Heart Committee Advisor
- The Rho Chi Society: Faculty Advisor
- Renal and Transplant Associates of New England, Springfield MA
- Ambulatory Care
- Ambulatory Care
- Dr. Wolff’s practice is within a Nephrology office in Springfield MA. She focuses primarily on preventing the progression of chronic kidney disease. She sees patients for polypharmacy, medication reconciliation, diabetes, cholesterol, and hypertension management. Additionally she works with the rest of the interdisciplinary team to provide education to patients with CKD and to post renal transplant patients.